1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow David VanderWeele: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer Ipatasertib, Darolutamide, Androgen Deprivation Therapy - Castrate Resistant Prostate Cancer | Phase 1 / Phase 2 | Terminated | David VanderWeele | 6 | 2021-07-13 | 2023-11-13 |
Androgen Antagonists (1) · darolutamide (1) · ipatasertib (1)
United States (1)